Navigation Links
Equatorial Guinea's [EG] Ministry of Health convenes in Washington, DC with GB Group Global and TNI Biotech (OTCBB:TNIB) to launch major innovative health solutions and improve pharmaceutical quality for its citizens
Date:4/8/2013

WASHINGTON, April 8, 2013 /PRNewswire/ -- EG Ministry of Health recently met with Dr. Gloria B. Herndon of GB Group Global in the nation's capital as part of Equatorial Guinea's efforts to drastically raise its standards of health care. These endeavors include building a pharmaceutical manufacturing facility in EG, implementing pharmaceutical quality control and policies, and exploring the release of a new treatment (Low Dose Naltrexone) against cancer and HIV/AIDS.

The purpose of the visit of Dr. Diosdado-Vicente Milang Nsue, the Delegate Minister of Health & Social Services and Dr. Consuelo Ondo Efua , the Director General of Drug Supply and Medical equipment, was to engage with organizations who through assistance, partnership and the sharing of best-practices could close medical knowledge gaps and help bring improved health care to Equatorial Guineans.

Among issues discussed, Minister Dr. Milang Nsue raised a problem rampant overseas: The need for affordable high quality medicines. "The devastating effects of substandard and counterfeit medicines in circulation lead to treatment failure, increased mortality and the development of drug resistance."

Dr. Milang stressed the fact that "...establishing in Equatorial Africa a pharmaceutical manufacturing facility with an analytical laboratory would be of paramount importance..." The proposed facility was part of conversations with TNI Biotech (OTCBB:TNIB), GB-Energie, GB-Pharma, Howard University and the United States Pharmacopeia representatives.

Dr. Ondo Efua said, "With the establishment of a drug manufacturing facility to treat the most current pathologies and a laboratory for drug quality control we could guarantee the safety and high quality of medicines either produced in EG or imported. We would have taken an important step to halt the traffic and commercialization of the counterfeit medicines that undermine the quality of the health services delivered to our population."

Further, as EG is concerned in the global struggle to combat the scourge of diseases such as HIV/AIDS and cancer, new developments regarding the therapy known as IRT-103 Low Dose Naltrexone were explained during the sessions.

Concluding the sessions, Dr. Herndon said she felt the exchanges had been productive and pleased that "...we (GB Group Global) were able to demonstrate our commitment to viable and sustainable solutions to the issues of the citizens well being and the growth of the nation."

www.gbenergie.com


'/>"/>
SOURCE GB Group Global
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AUL says New York Judges Ruling Allows Big Abortion to Gamble with Young Girls Health
2. Dynamic Healthcare Services Announces David Erb as Director of Sales
3. Healthcare Coalitions Across the Nation Band Together to Ready for Disasters
4. Kentucky Health Cooperative To Partner With ProCare Rx For Pharmacy Benefit Management
5. Assurex Health Appoints Chief Financial Officer and Payer Market Executive to Manage Rapid Growth in Personalized Medicine
6. Armada Health Care Achieves Full URAC Accreditation
7. Kimberly-Clark Health Care Acquires Anesthesia Business from Life-Tech
8. Healthrageous Unveils Accountable Health The Missing Piece To Engage Consumers In Their Health And Achieve Accountable Care Goals
9. Healthcare Tech developers ENuke Software LLC proud to announce completion of eBroselowLutens Artemis in Dutch, German, Portugese and Spanish
10. Everyday Health Expands Solutions For Pharmaceutical Industry Marketers
11. Saint Francis Signs Agreement to Upgrade and Extend the Use of Streamline Healths(R) Solutions for Five More Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2016)... 19, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... for the treatment of grievous blood-based disorders with significant ... be presented in a poster session at the European ... Copenhagen . The presentations will include additional ... sickle cell disease (SCD), including 90-day data from a ...
(Date:5/19/2016)... , May 19, 2016  IBM,s (NYSE:   IBM )  ... study to identify drug candidates to cure Zika, a ... declared a global public health emergency. IBM ... with a computer or Android device to join the ... or money to help; they simply  run an app ...
(Date:5/18/2016)... 19, 2016 Global ... Report initially provides a basic overview of ... manufacturing technology, post which the report explores ... the market. Complete report on ... providing 8 company profiles and 98 tables ...
Breaking Medicine Technology:
(Date:5/23/2016)... Angeles, CA (PRWEB) , ... May 23, 2016 ... ... to connecting doctors and patients to provide information about cosmetic procedures, began updating ... now started to rewrite each of their published articles in order to feature ...
(Date:5/23/2016)... , ... May 23, 2016 ... ... security executive networking and relationship-marketing firm, announced today that nominations will be ... Security Executive® (ISE®) Northeast Awards. , Awards include the Information Security Executive® ...
(Date:5/23/2016)... ... May 23, 2016 , ... ... residents of Westchester County for over 24 years, recently hosted its sixth annual ... joined HOW for two remembrance ceremonies, each concluding with the release of Monarch ...
(Date:5/23/2016)... ... May 23, 2016 , ... Overweight and obesity in children can ... the budget, but most of all, it can be hard on the child carrying ... diet food—isn’t making a dint in childhood obesity statistics or making it easier for ...
(Date:5/23/2016)... ... May 23, 2016 , ... A team of cardiovascular surgeons ... the first in the region to use a groundbreaking new technology to provide ... Program partnered with AHN to introduce the technology to the Pittsburgh market. , ...
Breaking Medicine News(10 mins):